Figure 1

In patients with PD and MSA, 18F-FD4 has consistently produced high-contrast signals in pathology-relevant brain regions and shown robust disease-differentiation performance

Format

JPEG

Source

ABLi Therapeutics

Figure 1

Format

Source

Downloads